BDX wins FDA 510(k) clearance for the EnCor EnCompass breast biopsy system, set for an early 2026 launch to boost flexibility and patient care.

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. From facial ...

Novo Nordisk has found a buyer for cell therapy technologies dropped in its retreat from the modality. Aspect Biosystems has ...

In Harlem, New York — a city with a population mostly made up of Hispanic, Latino, and Black families — white-dominated ...

While a majority of the therapies currently in development are life-long treatments, Genespire is taking a different approach ...

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...

Hall also recommends runners bring a headlamp or other source of light to help keep an eye on path conditions. From concrete ...

AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

Abstract: Remote sensing cross-modality text-image retrieval aims to retrieve a specific object from a large image gallery based on a natural language description, and vice versa. Existing methods ...

After winning a surprise approval for its hereditary angioedema drug Ekterly, KalVista is confident the oral offering will ...

Abstract: The discernment of jamming signal was important for the downstream tasks. Though great improvement was achieved by deep learning previously, these methods need large amounts of signals with ...